Hasil Pencarian (1)
small molecule | CAS: 171099-57-3
Oritavancin is a glycopeptide antibiotic used for the treatment of skin infections. It was developed by The Medicines Company (acquired by Novartis).[L12858] Oritavancin was initially approved by the FDA in 2014 and formulated to combat susceptible gram-posit…
Kategori:
Amino Acids, Peptides, and ProteinsAnti-Bacterial AgentsAnti-Infective Agents
+24
Target Protein:
Dihydropteroate synthasePeptidoglycan precursorsBacterial cell wall peptide bridging segments
+1
Waktu ParuhThe average termina…
Vol. DistribusiThe volume of distr…
KlirensThe clearance of or…
Genetik
-